Fisher Asset Management, LLC

Position in RDY — Dr Reddys Laboratories Ltd

CIK 850529 PLANO, TX

Position in RDY

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$2,619,313

-$2,432,405 QoQ

Shares Held

180,767

-50.4% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#50

of 238 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fisher Asset Management, LLC holds $131,969,402 across 8 Drug Manufacturers - Specialty & Generic names. RDY ranks #8 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BCRX	Biocryst Pharmaceuticals Inc	2,604,027	$26,040,270
2	KNSA	Kiniksa Pharmaceuticals International, plc	398,266	$25,469,110
3	NBIX	Neurocrine Biosciences Inc	135,104	$22,770,428
4	ALKS	Alkermes plc.	419,102	$21,960,944
5	UTHR	UNITED THERAPEUTICS Corp	33,836	$18,333,359
6	PBH	Prestige Consumer Healthcare Inc.	247,474	$11,698,095
7	HLN	Haleon plc	329,891	$3,077,883
8	RDY	Dr Reddys Laboratories Ltd This page	180,767	$2,619,313

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,619,313	180,767	-50.4%	Shares	Sole	2026-08-04
2026-03-31	$5,051,718	364,745	-27.9%	Shares	Sole	2026-05-05
2025-12-31	$7,104,843	506,043	-69.9%	Shares	Defined	2026-02-09
2025-09-30	$23,506,125	1,681,411	-16.7%	Shares	Defined	2025-11-12
2025-06-30	$30,353,310	2,019,515	-20.6%	Shares	Defined	2025-08-13
2025-03-31	$33,535,601	2,542,502	+3.0%	Shares	Defined	2025-05-14
2024-12-31	$38,981,120	2,468,722	+402.5%	Shares	Defined	2025-02-05
2024-09-30	$39,034,023	491,303	+59.4%	Shares	Defined	2024-11-12
2024-06-30	$23,478,481	308,157	-3.2%	Shares	Defined	2024-08-14
2024-03-31	$23,351,339	318,355	+55.1%	Shares	Defined	2024-05-09
2023-12-31	$14,283,382	205,280	+126.5%	Shares	Defined	2024-03-05
2023-09-30	$6,061,765	90,650	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.